Asia Pacific Biobanks Market to Grow at a CAGR of 7.1% to reach US$ 871.63 Million from 2021 to 2028

Asia Pacific Biobanks Market to 2027 - Regional Analysis and Forecasts by Product and Service (Equipment, Consumables, Service, and Software), Sample (Blood Products, Human Tissues, Cell Lines, and Others), and Application (Regenerative Medicine, Life Science Research, and Clinical Research)

  • Report Code : TIPRE00028369
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 172
Buy Now

The biobanks market in Asia Pacific is expected to grow from US$ 540.25 million in 2021 to US$ 871.63 million by 2028; it is estimated to grow at a CAGR of 7.1% from 2021 to 2028.

The biotechnology sector in Asia Pacific is proliferating with heavy investments and strategic developments between private and public organizations. For instance, in December 2019, Astellas Pharma Inc. (Japan) signed an agreement to acquire Audentes Therapeutics Inc., a gene therapy company, for US$ 3 billion. Similarly, in November 2019, Fujifilm invested ~US$ 120 million (JPY 13 billion) in gene therapy as a part of the contract development and manufacturing segment of the organization. In addition, the Japan Pharmaceutical Medical Device Agency approved two gene therapy products. The products were approved simultaneously under Sakigake designation, equivalent to the FDA breakthrough therapy designation, and the EMA Priority Medicine (PRIME) designation. The agency is expected to approve at least one therapy per year. Strategic developments in the cell therapy domain by the domestic players in Asian countries are likely to increase the demand for cell therapy in the coming years. Since the approval of Gendicine for the treatment of head-and-neck squamous cell carcinoma by substituting affected copies of the p53 tumor suppressor gene with normal gene copies, China has expanded cell therapy applications and increased cell therapy production. For instance, in 2018, Taiwan held the ninth position for a regulatory agency to approve cell therapy's clinical application. In January 2020, the country introduced six autologous cell therapy treatments, including two for cancer, two for skin cell transplantation, and two for bone and cartilage regeneration. In Taiwan, four hospitals have licenses to provide cell therapies, and 26 more hospitals have already applied for a license to provide cell therapies. Therefore, rising awareness and use of cell therapy is expected to propel the adoption of biobanking in Asia Pacific. Furthermore, regenerative medicine research in cell therapy, gene therapy, and tissue engineering is rapidly growing in Asia Pacific countries. Also, rising geriatric population; increasing developments in healthcare services; surging requirement for transplants; and emerging personalized medicines in Japan, China, India, and South Korea would create demand for biobanking in the future. Thus, increasing adoption of cell therapy in developing regions is expected to fuel the demand for biobanking, which is likely to offer various growth opportunities for the biobanks market players during the forecast period.

Countries in Asia Pacific are facing challenges due to increasing incidences of COVID-19. Shrinking economy of many countries is also going to affect many sectors including pharmaceutical. As per the Asian Development Bank (ADB), a group of 45 countries in the Asia Pacific region, is expected to post growth of just 0.1 per cent in 2020. The pandemic's expansion, combined with concerns about the economy's recovery, has harmed the region's pharmaceutical business. This economic impact is projected to have a detrimental influence on research and development investments. Some research institutes in the region are actively participating in research to determine the feasibility of coronavirus management. The coronavirus disease 2019 (COVID-19) pandemic has hampered non-communicable disease detection and treatment. COVID-19 was associated with a significant and abrupt reduction in cardiovascular diagnostic testing across the Asia pacific, especially affecting the worlds economically challenged.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Asia Pacific biobanks market. The Asia Pacific biobanks market is expected to grow at a good CAGR during the forecast period.

Asia Pacific Biobanks Market Segmentation

Asia Pacific Biobanks Market – By Product and Service

  • Equipment
    • Storage Equipment
    • Sample Analysis Equipment
    • Sample Processing Equipment
    • Sample Transport Equipment
  • Consumables
    • Storage Consumables
    • Analysis Consumables
    • Processing Consumables
    • Collection Consumables
  • Service
    • Storage Services
    • Processing Services
    • Transport Services
    • Supply Services
  • Software

Asia Pacific Biobanks Market – By Sample

  • Blood Products
  • Human Tissues
  • Cell Lines
  • Others

Asia Pacific Biobanks Market – By Application

  • Regenerative Medicine
  • Life Science Research
  • Clinical Research

Asia Pacific Biobanks Market – By Country

  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of APAC

Asia Pacific Biobanks Market – Companies Mentioned

  • THERMO FISHER SCIENTIFIC INC.
  • Tecan Trading AG
  • QIAGEN
  • Hamilton Company
  • Avantor, Inc.
  • MICRONICS JAPAN CO., LTD.
  • BD
  • Taylor-Wharton
  • Brooks Automation, Inc.
  • Promega Corporation
  • SciSafe Inc.     
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

  1. THERMO FISHER SCIENTIFIC INC.
  2. Tecan Trading AG
  3. QIAGEN
  4. Hamilton Company
  5. Avantor, Inc.
  6. MICRONICS JAPAN CO., LTD.
  7. BD
  8. Taylor-Wharton
  9. Brooks Automation, Inc.
  10. Promega Corporation
  11. SciSafe Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Asia Pacific Biobanks Market